Cannabis and adolescent brain development

Pharmacology and Therapeutics

Volumn 148, Issue , 2015, Pages 1-16

  Lubman, Dan I ^a   Cheetham, Ali ^a   Yücel, Murat ^a,b  

^a MONASH UNIVERSITY   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Adolescence; Brain development; Cannabis; Cognition; Endocannabinoid; Mental illness

Indexed keywords

ENDOCANNABINOID; MEDICAL CANNABIS; CANNABINOID; CANNABIS;

ADOLESCENT; ADOLESCENT DEVELOPMENT; ARTICLE; BRAIN DEVELOPMENT; BRAIN FUNCTION; BRAIN REGION; CANNABIS USE; COGNITION; COGNITIVE DEFECT; DEPRESSION; DIFFUSION TENSOR IMAGING; DRUG EFFECT; DRUG EXPOSURE; DRUG MECHANISM; EMOTIONAL DISORDER; HUMAN; LEARNING DISORDER; LONG TERM EXPOSURE; MEMORY DISORDER; NEUROPROTECTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRENATAL PERIOD; PRIORITY JOURNAL; SCHIZOPHRENIA; SHORT TERM MEMORY; WORKING MEMORY; ANIMAL; BRAIN; DRUG EFFECTS; FEMALE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PREGNANCY; PRENATAL EXPOSURE;

ADOLESCENT; ANIMALS; BRAIN; CANNABINOIDS; CANNABIS; DEPRESSION; ENDOCANNABINOIDS; FEMALE; HUMANS; LEARNING DISORDERS; MEMORY DISORDERS; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA;

EID: 84923276372     PISSN: 01637258     EISSN: 1879016X     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2014.11.009     Document Type: Review

References (301)

1. H. Abush, and I. Akirav Short- and long-term cognitive effects of chronic cannabinoids administration in late-adolescence rats PLoS One 7 2 2012 e31731
2. A. Agrawal, E.C. Nelson, A.K. Littlefield, K.K. Bucholz, L. Degenhardt, and A.K. Henders Cannabinoid receptor (CNR1) genotype moderates the effects of childhood physical abuse on anhedonia and depression Arch Gen Psychiatry 69 7 2012 732 740
3. V. Ajdacic-Gross, C. Lauber, I. Warnke, H. Haker, R.M. Murray, and W. Rössler Changing incidence of psychotic disorders among the young in Zurich Schizophr Res 95 1 2007 9 18
4. S. Alemany, B. Arias, and M. Fatjó Vilas Psychosisinducing effects of cannabis are related to both childhood abuse and COMT genotypes Acta Psychiatr Scand 129 1 2014 54 62
5. F.J. Alvarez, H. Lafuente, and M.C. Rey-Santano Neuroprotective effects of the nonpsychoactive cannabinoid cannabidiol in hypoxic-ischemic newborn piglets Pediatr Res 64 6 2008 653 658
6. H. Amal, L. Fridman-Rozevich, R. Senn, A. Strelnikov, M. Gafni, and O. Keren Long-term consequences of a single treatment of mice with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) Behav Brain Res 206 2 2010 245 253
7. D.G. Amen, and M. Waugh High resolution brain SPECT imaging of marijuana smokers with AD/HD J Psychoactive Drugs 30 2 1998 209 214
8. T. Antonelli, M.C. Tomasini, M. Tattoli, T. Cassano, S. Tanganelli, and S. Finetti Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and emotional reactivity changes in rat offspring Cereb Cortex 15 12 2005 2013 2020
9. Á. ArévaloMartín, D. GarcíaOvejero, A. RubioAraiz, O. Gómez, F. MolinaHolgado, and E. MolinaHolgado Cannabinoids modulate Olig2 and polysialylated neural cell adhesion molecule expression in the subventricular zone of postnatal rats through cannabinoid receptor 1 and cannabinoid receptor 2 Eur J Neurosci 26 6 2007 1548 1559
10. J. Arnold, A. Boucher, and T. Karl The yin and yang of cannabis-induced psychosis: the actions of Δ(9)-tetrahydrocannabinol and cannabidiol in rodent models of schizophrenia Curr Pharm Des 18 32 2012 5113 5130
11. D. Arnone, T.R. Barrick, S. Chengappa, C. Mackay, C.A. Clark, and M. Abou-Saleh Corpus callosum damage in heavy marijuana use: preliminary evidence from diffusion tensor tractography and tract-based spatial statistics Neuroimage 41 3 2008 1067 1074
12. L. Arseneault, M. Cannon, R. Poulton, R. Murray, A. Caspi, and T.E. Moffitt Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study BMJ 325 7374 2002 1212 1213
13. M. Ashtari, B. Avants, L. Cyckowski, K.L. Cervellione, D. Roofeh, and P. Cook Medial temporal structures and memory functions in adolescents with heavy cannabis use J Psychiatr Res 45 8 2011 1055 1066
14. M. Ashtari, K. Cervellione, J. Cottone, B.A. Ardekani, and S. Kumra Diffusion abnormalities in adolescents and young adults with a history of heavy cannabis use J Psychiatr Res 43 3 2009 189 204
15. F. Assaf, M. Fishbein, M. Gafni, O. Keren, and Y. Sarne Pre- and post-conditioning treatment with an ultra-low dose of Δ9-tetrahydrocannabinol (THC) protects against pentylenetetrazole (PTZ)-induced cognitive damage Behav Brain Res 220 1 2011 194 201
16. P. Atsak, D. Hauer, P. Campolongo, G. Schelling, J.L. McGaugh, and B. Roozendaal Glucocorticoids interact with the hippocampal endocannabinoid system in impairing retrieval of contextual fear memory Proc Natl Acad Sci 109 9 2012 3504 3509
17. S.T. Baker, M. Yücel, A. Fornito, N.B. Allen, and D.I. Lubman A systematic review of diffusion weighted MRI studies of white matter microstructure in adolescent substance users Neurosci Biobehav Rev 37 8 2013 1713 1723
18. F.R. Bambico, N.-T. Nguyen, N. Katz, and G. Gobbi Chronic exposure to cannabinoids during adolescence but not during adulthood impairs emotional behaviour and monoaminergic neurotransmission Neurobiol Dis 37 3 2010 641 655
19. A. Batalla, S. Bhattacharyya, M. Yücel, P. Fusar-Poli, J.A. Crippa, and S. Nogué Structural and functional imaging studies in chronic cannabis users: a systematic review of adolescent and adult findings PLoS One 8 2 2013 e55821
20. S. Bava, J. Jacobus, R.E. Thayer, and S.F. Tapert Longitudinal changes in white matter integrity among adolescent substance users Alcohol Clin Exp Res 37 s1 2013 E181 E189
21. T.A. Bayer, P. Falkai, and W. Maier Genetic and non-genetic vulnerability factors in schizophrenia: the basis of the "two hit hypothesis" J Psychiatr Res 33 6 1999 543 548
22. M.M. Bergamaschi, R.H.C. Queiroz, M.H.N. Chagas, D.C.G. de Oliveira, B.S. De Martinis, and F. Kapczinski Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naive social phobia patients Neuropsychopharmacology 36 6 2011 1219 1226
23. F. Berrendero, L. Garcia-Gil, M. Hernandez, J. Romero, M. Cebeira, and R. De Miguel Localization of mRNA expression and activation of signal transduction mechanisms for cannabinoid receptor in rat brain during fetal development Development 125 16 1998 3179 3188
24. R.I. Block, D.S. O'Leary, J.C. Ehrhardt, J.C. Augustinack, M.M. Ghoneim, and S. Arndt Effects of frequent marijuana use on brain tissue volume and composition Neuroreport 11 3 2000 491 496
25. K.I. Bolla, K. Brown, D. Eldreth, K. Tate, and J. Cadet Dose-related neurocognitive effects of marijuana use Neurology 59 9 2002 1337 1343
26. M.G. Bossong, and R.J. Niesink Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia Prog Neurobiol 92 3 2010 370 385
27. J. Boydell, J. Van Os, A. Caspi, N. Kennedy, E. Giouroukou, and P. Fearon Trends in cannabis use prior to first presentation with schizophrenia, in south-east London between 1965 and 1999 Psychol Med 36 10 2006 1441 1446
28. S.I. Brook, H.H. López, and A.J. Saylor Chronic cannabinoid treatment in adolescence attenuates c-Fos expression in nucleus accumbens of adult estrous rats Impulse 2013 1 15
29. J.E. Bruin, H.C. Gerstein, and A.C. Holloway Long-term consequences of fetal and neonatal nicotine exposure: a critical review Toxicol Sci 116 2 2010 364 374
30. A. Caballero, and K.Y. Tseng Association of cannabis use during adolescence, prefrontal CB1 receptor signaling, and schizophrenia Front Pharmacol 3 2012 101
31. V.A. Campbell Tetrahydrocannabinol-induced apoptosis of cultured cortical neurones is associated with cytochrome c release and caspase-3 activation Neuropharmacology 40 5 2001 702 709
32. K. Campbell, T. Foster, R. Hampson, and S. Deadwyler Δ9-Tetrahydrocannabinol differentially affects sensory-evoked potentials in the rat dentate gyrus J Pharmacol Exp Ther 239 3 1986 936 940
33. A.C. Campos, and F.S. Guimarães Involvement of 5HT1A receptors in the anxiolytic-like effects of cannabidiol injected into the dorsolateral periaqueductal gray of rats Psychopharmacology (Berl) 199 2 2008 223 230
34. A.C. Campos, F.A. Moreira, F.V. Gomes, E.A. Del Bel, and F.S. Guimaraes Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders Philos Trans R Soc Lond B Biol Sci 367 1607 2012 3364 3378
35. A.C. Campos, Z. Ortega, J. Palazuelos, M.V. Fogaça, D.C. Aguiar, and J. Diaz-Alonso The anxiolytic effect of cannabidiol on chronically stressed mice depends on hippocampal neurogenesis: involvement of the endocannabinoid system Int J Neuropsychopharmacol 16 06 2013 1407 1419
36. E. Carlini The good and the bad effects of -trans-Δ9-tetrahydrocannabinol (Δ9THC) on humans Toxicon 44 4 2004 461 467
37. A. Caspi, T.E. Moffitt, M. Cannon, J. McClay, R. Murray, and H. Harrington Moderation of the effect of adolescent-onset cannabis use on adult psychosis by a functional polymorphism in the catechol-O-methyltransferase gene: longitudinal evidence of a gene × environment interaction Biol Psychiatry 57 10 2005 1117 1127
38. P. Castaldo, S. Magi, S. Gaetani, T. Cassano, L. Ferraro, and T. Antonelli Prenatal exposure to the cannabinoid receptor agonist WIN 55,212-2 increases glutamate uptake through overexpression of GLT1 and EAAC1 glutamate transporter subtypes in rat frontal cerebral cortex Neuropharmacology 53 3 2007 369 378
39. M.V. Catania, S. D'Antoni, C.M. Bonaccorso, E. Aronica, M.F. Bear, and F. Nicoletti Group I metabotropic glutamate receptors: a role in neurodevelopmental disorders? Mol Neurobiol 35 3 2007 298 307
40. J. Ceccarini, M. De Hert, R. Van Winkel, J. Peuskens, G. Bormans, and L. Kranaster Increased ventral striatal CB1 receptor binding is related to negative symptoms in drug-free patients with schizophrenia Neuroimage 79 2013 304 312
41. Y.M. Cha, A.M. White, C.M. Kuhn, W.A. Wilson, and H. Swartzwelder Differential effects of Δ9THC on learning in adolescent and adult rats Pharmacol Biochem Behav 83 3 2006 448 455
42. B. Chadwick, A.J. Saylor, and H.H. López Adolescent cannabinoid exposure attenuates adult female sexual motivation but does not alter adulthood CB1R expression or estrous cyclicity Pharmacol Biochem Behav 100 1 2011 157 164
43. A. Cheetham, N.B. Allen, S. Whittle, J.G. Simmons, M. Yücel, and D.I. Lubman Orbitofrontal volumes in early adolescence predict initiation of cannabis use: a 4-year longitudinal and prospective study Biol Psychiatry 71 8 2012 684 692
44. J.C. Churchwell, M. Lopez-Larson, and D.A. Yurgelun-Todd Altered frontal cortical volume and decision making in adolescent cannabis users Front Psychol 1 2010
45. D.B. Clark, T. Chung, D.L. Thatcher, S. Pajtek, and E.C. Long Psychological dysregulation, white matter disorganization and substance use disorders in adolescence Addiction 107 1 2012 206 214
46. J. Cookey, D. Bernier, and P.G. Tibbo White matter changes in early phase schizophrenia and cannabis use: an update and systematic review of diffusion tensor imaging studies Schizophr Res 156 2 2014 137 142
47. R.D. Crean, N.A. Crane, and B.J. Mason An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions J Addict Med 5 1 2011 1 8
48. J.A. Crippa, A.W. Zuardi, R. Martin-Santos, S. Bhattacharyya, Z. Atakan, and P. McGuire Cannabis and anxiety: a critical review of the evidence Hum Psychopharmacol 24 7 2009 515 523
49. D.C. D'Souza, B. Pittman, E. Perry, and A. Simen Preliminary evidence of cannabinoid effects on brain-derived neurotrophic factor (BDNF) levels in humans Psychopharmacology (Berl) 202 4 2009 569 578
50. V.S. Dalton, and K. Zavitsanou Cannabinoid effects on CB1 receptor density in the adolescent brain: an autoradiographic study using the synthetic cannabinoid HU210 Synapse 64 11 2010 845 854
51. M. Daly Personality may explain the association between cannabis use and neuropsychological impairment Proc Natl Acad Sci 110 11 2013 E979
52. N.L. Day, S.L. Leech, and L. Goldschmidt The effects of prenatal marijuana exposure on delinquent behaviors are mediated by measures of neurocognitive functioning Neurotoxicol Teratol 33 1 2011 129 136
53. L. De Oliveira Alvares, B.P. Genro, F. Diehl, and J.A. Quillfeldt Differential role of the hippocampal endocannabinoid system in the memory consolidation and retrieval mechanisms Neurobiol Learn Mem 90 1 2008 1 9
54. L. De Petrocellis, and V. Di Marzo An introduction to the endocannabinoid system: from the early to the latest concepts Best Pract Res Clin Endocrinol Metab 23 1 2009 1 15
55. 3H] CP-55940 binding in the human central nervous system: regional specific changes in density of cannabinoid-1 receptors associated with schizophrenia and cannabis use Neuroscience 103 1 2001 9 15
56. L. Degenhardt, W. Hall, and M. Lynskey Exploring the association between cannabis use and depression Addiction 98 11 2003 1493 1504
57. L.E. DeLisi, H.C. Bertisch, K.U. Szulc, M. Majcher, K. Brown, and A. Bappal A preliminary DTI study showing no brain structural change associated with adolescent cannabis use Harm Reduct J 3 1 2006 17
58. T. Demirakca, A. Sartorius, G. Ende, N. Meyer, H. Welzel, and G. Skopp Diminished gray matter in the hippocampus of cannabis users: possible protective effects of cannabidiol Drug Alcohol Depend 114 2 2011 242 245
59. C. Derauf, M. Kekatpure, N. Neyzi, B. Lester, and B. Kosofsky Neuroimaging of children following prenatal drug exposure Seminars in cell & developmental biology Vol. 20 2009 Elsevier 441 454
60. J. Díaz-Alonso, M. Guzmán, and I. Galve-Roperh Endocannabinoids via CB1 receptors act as neurogenic niche cues during cortical development Philos Trans R Soc Lond B Biol Sci 367 1607 2012 3229 3241
61. K. Domschke, U. Dannlowski, P. Ohrmann, B. Lawford, J. Bauer, and H. Kugel Cannabinoid receptor 1 (CNR1) gene: impact on antidepressant treatment response and emotion processing in major depression Eur Neuropsychopharmacol 18 10 2008 751 759
62. E.J. Downer, B. Boland, M. Fogarty, and V. Campbell Δ9-Tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor Neuroreport 12 18 2001 3973 3978
63. E.J. Downer, and V.A. Campbell Phytocannabinoids, CNS cells and development: a dead issue? Drug Alcohol Rev 29 1 2010 91 98
64. E.J. Downer, A. Gowran, and V.A. Campbell A comparison of the apoptotic effect of Δ9-tetrahydrocannabinol in the neonatal and adult rat cerebral cortex Brain Res 1175 2007 39 47
65. D.C. D'Souza, E. Perry, L. MacDougall, Y. Ammerman, T. Cooper, and Y-t. Wu The psychotomimetic effects of intravenous delta-9-tetrahydrocannabinol in healthy individuals: implications for psychosis Neuropsychopharmacology 29 8 2004 1558 1572
66. R.H. DuRant, J.A. Smith, S.R. Kreiter, and D.P. Krowchuk The relationship between early age of onset of initial substance use and engaging in multiple health risk behaviors among young adolescents Arch Pediatr Adolesc Med 153 3 1999 286 291
67. A. Egerton, C. Allison, R.R. Brett, and J.A. Pratt Cannabinoids and prefrontal cortical function: insights from preclinical studies Neurosci Biobehav Rev 30 5 2006 680 695
68. S.M. Eggan, S.R. Stoyak, C.D. Verrico, and D.A. Lewis Cannabinoid CB1 receptor immunoreactivity in the prefrontal cortex: comparison of schizophrenia and major depressive disorder Neuropsychopharmacology 35 10 2010 2060 2071
69. H. el Marroun, H. Tiemeier, and V.W. Jaddoe Demographic, emotional and social determinants of cannabis use in early pregnancy: the Generation R study Drug Alcohol Depend 98 3 2008 218 226
70. A.T. El-Alfy, K. Ivey, and K. Robinson Antidepressant-like effect of Δ9-tetrahydrocannabinol and other cannabinoids isolated from Cannabis sativa L. Pharmacol Biochem Behav 95 4 2010 434 442
71. M.B. Elliott, R.F. Tuma, P.S. Amenta, M.F. Barbe, and J.I. Jallo Acute effects of a selective cannabinoid-2 receptor agonist on neuroinflammation in a model of traumatic brain injury J Neurotrauma 28 6 2011 973 981
72. I. Feinberg Schizophrenia: caused by a fault in programmed synaptic elimination during adolescence? J Psychiatr Res 17 4 1983 319 334
73. D.M. Fergusson, L. Horwood, and N. Swain-Campbell Cannabis dependence and psychotic symptoms in young people Psychol Med 33 1 2003 15 21
74. D. Fernández-López, J. Faustino, N. Derugin, M. Wendland, I. Lizasoain, and M.A. Moro Reduced infarct size and accumulation of microglia in rats treated with WIN 55,212-2 after neonatal stroke Neuroscience 207 2012 307 315
75. D. Fernández-López, J.M. Pradillo, I. García-Yébenes, J.A. Martínez-Orgado, M.A. Moro, and I. Lizasoain The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia Stroke 41 12 2010 2956 2964
76. F. Ferrari, A. Ottani, R. Vivoli, and D. Giuliani Learning impairment produced in rats by the cannabinoid agonist HU 210 in a water-maze task Pharmacol Biochem Behav 64 3 1999 555 561
77. R. Ferretjans, F.A. Moreira, A.L. Teixeira, and J.V. Salgado The endocannabinoid system and its role in schizophrenia: a systematic review of the literature Rev Bras Psiquiatr 34 2012 163 193
78. M. Fishbein, S. Gov, F. Assaf, M. Gafni, O. Keren, and Y. Sarne Long-term behavioral and biochemical effects of an ultra-low dose of Δ9-tetrahydrocannabinol (THC): neuroprotection and ERK signaling Exp Brain Res 221 4 2012 437 448
79. M.A. Fontes, K.I. Bolla, P.J. Cunha, P.P. Almeida, F. Jungermann, and R.R. Laranjeira Cannabis use before age 15 and subsequenct executive functioning Br J Psychiatry 198 2011 442 447
80. C.S. Freedland, C.T. Whitlow, M.D. Miller, and L.J. Porrino Dosedependent effects of Δ9tetrahydrocannabinol on rates of local cerebral glucose utilization in rat Synapse 45 2 2002 134 142
81. T.F. Freund, I. Katona, and D. Piomelli Role of endogenous cannabinoids in synaptic signaling Physiol Rev 83 3 2003 1017 1066
82. E. Fride Multiple roles for the endocannabinoid system during the earliest stages of life: preand postnatal development J Neuroendocrinol 20 s1 2008 75 81
83. P. Fried, and B. Watkinson 36- and 48-month neurobehavioral follow-up of children prenatally exposed to marijuana, cigarettes, and alcohol J Dev Behav Pediatr 11 2 1990 49 58
84. P. Fried, and B. Watkinson Differential effects on facets of attention in adolescents prenatally exposed to cigarettes and marihuana Neurotoxicol Teratol 23 5 2001 421 430
85. P. Fried, B. Watkinson, and R. Gray Differential effects on cognitive functioning 9- to 12-year olds prenatally exposed to cigarettes and marihuana Neurotoxicol Teratol 20 3 1998 293 306
86. P. Fried, B. Watkinson, and R. Gray Neurocognitive consequences of marihuana - a comparison with pre-drug performance Neurotoxicol Teratol 27 2 2005 231 239
87. I. Galve-Roperh Cannabis, endocannabinoids and neurodevelopment Marijuana and Madness 2012 66
88. I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzmán The endocannabinoid system and neurogenesis in health and disease Neuroscientist 13 2 2007 109 114
89. I. Galve-Roperh, T. Aguado, J. Palazuelos, and M. Guzmán Mechanisms of control of neuron survival by the endocannabinoid system Curr Pharm Des 14 23 2008 2279 2288
90. I. Galve-Roperh, J. Palazuelos, T. Aguado, and M. Guzmán The endocannabinoid system and the regulation of neural development: potential implications in psychiatric disorders Eur Arch Psychiatry Clin Neurosci 259 7 2009 371 382
91. J.N. Giedd, J. Blumenthal, N.O. Jeffries, F.X. Castellanos, H. Liu, and A. Zijdenbos Brain development during childhood and adolescence: a longitudinal MRI study Nat Neurosci 2 10 1999 861 863
92. J.N. Giedd, F.M. Lalonde, M.J. Celano, S.L. White, G.L. Wallace, and N.R. Lee Anatomical brain magnetic resonance imaging of typically developing children and adolescents J Am Acad Child Adolesc Psychiatry 48 5 2009 465 470
93. K.H. Ginzel, G.S. Maritz, and D.F. Marks Critical review nicotine for the fetus, the infant and the adolescent? J Health Psychol 12 2 2007 215 224
94. K. Gleason, S. Birnbaum, A. Shukla, and S. Ghose Susceptibility of the adolescent brain to cannabinoids: long-term hippocampal effects and relevance to schizophrenia Transl Psychiatry 2 11 2012 e199
95. L. Goldschmidt, N.L. Day, and G.A. Richardson Effects of prenatal marijuana exposure on child behavior problems at age 10 Neurotoxicol Teratol 22 3 2000 325 336
96. L. Goldschmidt, G.A. Richardson, M.D. Cornelius, and N.L. Day Prenatal marijuana and alcohol exposure and academic achievement at age 10 Neurotoxicol Teratol 26 4 2004 521 532
97. L. Goldschmidt, G.A. Richardson, J. Willford, and N.L. Day Prenatal marijuana exposure and intelligence test performance at age 6 J Am Acad Child Adolesc Psychiatry 47 3 2008 254 263
98. R. Gonzalez Acute and non-acute effects of cannabis on brain functioning and neuropsychological performance Neuropsychol Rev 17 3 2007 347 361
99. I.I. Gottesman, and T.D. Gould The endophenotype concept in psychiatry: etymology and strategic intentions Am J Psychiatry 160 4 2003 636 645
100. B. Green, D. Kavanagh, and R. Young Being stoned: a review of selfreported cannabis effects Drug Alcohol Rev 22 4 2003 453 460
101. E. Grigorenko, J. Kittler, C. Clayton, D. Wallace, S. Zhuang, and D. Bridges Assessment of cannabinoid induced gene changes: tolerance and neuroprotection Chem Phys Lipids 121 1 2002 257 266
102. S.A. Gruber, M.K. Dahlgren, K.A. Sagar, A. Gönenç, and S.E. Lukas Worth the wait: effects of age of onset of marijuana use on white matter and impulsivity Psychopharmacology (Berl) 231 8 2014 1455 1465
103. S.A. Gruber, K.A. Sagar, M.K. Dahlgren, M. Racine, and S.E. Lukas Age of onset of marijuana use and executive function Psychol Addict Behav 26 3 2012 496
104. S.A. Gruber, M.M. Silveri, M.K. Dahlgren, and D. Yurgelun-Todd Why so impulsive? White matter alterations are associated with impulsivity in chronic marijuana smokers Exp Clin Psychopharmacol 19 3 2011 231
105. S.A. Gruber, and D.A. Yurgelun-Todd Neuroimaging of marijuana smokers during inhibitory processing: a pilot investigation Cogn Brain Res 23 1 2005 107 118
106. M. Guzmán, C. Sánchez, and I. Galve-Roperh Control of the cell survival/death decision by cannabinoids J Mol Med 78 11 2001 613 625
107. W. Hall, and L. Degenhardt Adverse health effects of non-medical cannabis use Lancet 374 9698 2009 1383 1391
108. W. Hall, and R.L. Pacula Cannabis Use and Dependence: Public Health and Public Policy 2003 Cambridge University Press
109. K.L. Hanson, J.L. Winward, A.D. Schweinsburg, K.L. Medina, S.A. Brown, and S.F. Tapert Longitudinal study of cognition among adolescent marijuana users over three weeks of abstinence Addict Behav 35 11 2010 970 976
110. T. Harkany, E. Keimpema, K. Barabás, and J. Mulder Endocannabinoid functions controlling neuronal specification during brain development Mol Cell Endocrinol 286 1 2008 S84 S90
111. M. Harley, I. Kelleher, M. Clarke, F. Lynch, L. Arseneault, and D. Connor Cannabis use and childhood trauma interact additively to increase the risk of psychotic symptoms in adolescence Psychol Med 40 10 2010 1627 1634
112. J.W. Harper, R.G. Heath, and W.A. Myers Effects of Cannabis sativa on ultrastructure of the synapse in monkey brain J Neurosci Res 3 2 1977 87 93
113. C.L. Hart, W. Van Gorp, M. Haney, R.W. Foltin, and M.W. Fischman Effects of acute smoked marijuana on complex cognitive performance Neuropsychopharmacology 25 5 2001 757 765
114. B.K. Hartman, H.C. Agrawal, D. Agrawal, and S. Kalmbach Development and maturation of central nervous system myelin: comparison of immunohistochemical localization of proteolipid protein and basic protein in myelin and oligodendrocytes Proc Natl Acad Sci 79 13 1982 4217 4220
115. M.A. Harvey, M.A. Harvey, J.D. Sellman, M.A. Harvey, J.D. Sellman, and R.J. Porter The relationship between non-acute adolescent cannabis use and cognition Drug Alcohol Rev 26 3 2007 309 319
116. R.G. Heath, A. Fitzjarrell, C.J. Fontana, and R. Garey Cannabis sativa: effects on brain function and ultrastructure in rhesus monkeys Biol Psychiatry 15 5 1980 657 690
117. C. Henquet, M. Di Forti, P. Morrison, R. Kuepper, and R.M. Murray Gene-environment interplay between cannabis and psychosis Schizophr Bull 34 6 2008 1111 1121
118. M. Herkenham, A.B. Lynn, M.D. Little, M.R. Johnson, L.S. Melvin, and B.R. De Costa Cannabinoid receptor localization in brain Proc Natl Acad Sci 87 5 1990 1932 1936
119. R.I. Herning, W.E. Better, K. Tate, and J.L. Cadet Cerebrovascular perfusion in marijuana users during a month of monitored abstinence Neurology 64 3 2005 488 493
120. C.J. Heyser, R.E. Hampson, and S.A. Deadwyler Effects of delta-9-tetrahydrocannabinol on delayed match to sample performance in rats: alterations in short-term memory associated with changes in task specific firing of hippocampal cells J Pharmacol Exp Ther 264 1 1993 294 307
121. M. Hickman, P. Vickerman, J. Macleod, J. Kirkbride, and P.B. Jones Cannabis and schizophrenia: model projections of the impact of the rise in cannabis use on historical and future trends in schizophrenia in England and Wales Addiction 102 4 2007 597 606
122. M.N. Hill, D.J. Froc, C.J. Fox, B.B. Gorzalka, and B.R. Christie Prolonged cannabinoid treatment results in spatial working memory deficits and impaired longterm potentiation in the CA1 region of the hippocampus in vivo Eur J Neurosci 20 3 2004 859 863
123. J.E. Houston, J. Murphy, G. Adamson, M. Stringer, and M. Shevlin Childhood sexual abuse, early cannabis use, and psychosis: testing an interaction model based on the National Comorbidity Survey Schizophr Bull 34 3 2008 580 585
124. S. Hu, W.S. Sheng, and R.B. Rock CB2 Receptor agonists protect human dopaminergic neurons against damage from HIV-1 gp120 PLoS One 8 10 2013 e77577
125. A.C. Huizink Prenatal cannabis exposure and infant outcomes: overview of studies Prog Neuropsychopharmacol Biol Psychiatry 52 2014 45 52
126. A.C. Huizink, and E.J. Mulder Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring Neurosci Biobehav Rev 30 1 2006 24 41
127. L.A. Hulvershorn, K. Cullen, and A. Anand Toward dysfunctional connectivity: a review of neuroimaging findings in pediatric major depressive disorder Brain Imaging Behav 5 4 2011 307 328
128. 35S] GTPγS binding in the prefrontal cortex of depressed suicide victims Mol Psychiatry 9 2 2004 184 190
129. A.B. Ilan, M.E. Smith, and A. Gevins Effects of marijuana on neurophysiological signals of working and episodic memory Psychopharmacology (Berl) 176 2 2004 214 222
130. J. Jacobus, S. Bava, M. Cohen-Zion, O. Mahmood, and S. Tapert Functional consequences of marijuana use in adolescents Pharmacol Biochem Behav 92 4 2009 559 565
131. J. Jacobus, T. McQueeny, S. Bava, B. Schweinsburg, L. Frank, and T. Yang White matter integrity in adolescents with histories of marijuana use and binge drinking Neurotoxicol Teratol 31 6 2009 349 355
132. J. Jacobus, L.M. Squeglia, S. Bava, and S.F. Tapert White matter characterization of adolescent binge drinking with and without co-occurring marijuana use: a 3-year investigation Psychiatry Res Neuroimaging 214 3 2013 374 381
133. J. Jacobus, L.M. Squeglia, M.A. Infante, S. Bava, and S.F. Tapert White matter integrity pre- and post marijuana and alcohol initiation in adolescence Brain Sci 3 1 2013 396 414
134. G. Jager, H.H. Van Hell, M.M. De Win, R.S. Kahn, W. Van Den Brink, and J.M. Van Ree Effects of frequent cannabis use on hippocampal activity during an associative memory task Eur Neuropsychopharmacol 17 4 2007 289 297
135. W. Jiang, Y. Zhang, L. Xiao, J. Van Cleemput, S-P Ji, and G. Bai Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects J Clin Invest 115 11 2005 3104 3116
136. G. Juhasz, D. Chase, E. Pegg, D. Downey, Z.G. Toth, and K. Stones CNR1 gene is associated with high neuroticism and low agreeableness and interacts with recent negative life events to predict current depressive symptoms Neuropsychopharmacology 34 8 2009 2019 2027
137. M.S. Keshavan, S. Anderson, and J.W. Pettergrew Is schizophrenia due to excessive synaptic pruning in the prefrontal cortex? The Feinberg hypothesis revisited J Psychiatr Res 28 3 1994 239 265
138. J.T. Kittler, E.V. Grigorenko, C. Clayton, S.-Y. Zhuang, S.C. Bundey, and M.M. Trower Large-scale analysis of gene expression changes during acute and chronic exposure to Δ9-THC in rats Physiol Genomics 3 3 2000 175 185
139. A. Klegeris, C.J. Bissonnette, and P.L. McGeer Reduction of human monocytic cell neurotoxicity and cytokine secretion by ligands of the cannabinoidtype CB2 receptor Br J Pharmacol 139 4 2003 775 786
140. T.W. Klein Cannabinoid-based drugs as anti-inflammatory therapeutics Nat Rev Immunol 5 5 2005 400 411
141. M. Klug, and M. van den Buuse Chronic cannabinoid treatment during young adulthood induces sex-specific behavioural deficits in maternally separated rats Behav Brain Res 233 2 2012 305 313
142. M. Klug, and M. Van Den Buuse An investigation into "two hit" effects of BDNF deficiency and young-adult cannabinoid receptor stimulation on prepulse inhibition regulation and memory in mice Front Behav Neurosci 7 2013
143. D. Koethe, I. Llenos, J. Dulay, C. Hoyer, E. Torrey, and F. Leweke Expression of CB1 cannabinoid receptor in the anterior cingulate cortex in schizophrenia, bipolar disorder, and major depression J Neural Transm 114 8 2007 1055 1063
144. R. Kuepper, J. van Os, R. Lieb, H.-U. Wittchen, M. Höfler, and C. Henquet Continued cannabis use and risk of incidence and persistence of psychotic symptoms: 10 year follow-up cohort study Br Med J 342 2011
145. A.M. Kumar, M. Haney, T. Becker, M.L. Thompson, R.M. Kream, and K. Miczek Effect of early exposure to Δ-9-tetrahydrocannabinol on the levels of opioid peptides, gonadotropin-releasing hormone and substance P in the adult male rat brain Brain Res 525 1 1990 78 83
146. H. Lafuente, F.J. Alvarez, and M.R. Pazos Cannabidiol reduces brain damage and improves functional recovery after acute hypoxia-ischemia in newborn pigs Pediatr Res 70 3 2011 272 277
147. P.W. Landfield, L.B. Cadwallader, and S. Vinsant Quantitative changes in hippocampal structure following long-term exposure to Δ9-tetrahydrocannabinol: possible mediation by glucocorticoid systems Brain Res 443 1 1988 47 62
148. S.D. Lane, D.R. Cherek, L.M. Lieving, and O.V. Tcheremissine Marijuana effects on human forgetting functions J Exp Anal Behav 83 1 2005 67 83
149. S.D. Lane, D.R. Cherek, O.V. Tcheremissine, J.L. Steinberg, and J.L. Sharon Response perseveration and adaptation in heavy marijuana-smoking adolescents Addict Behav 32 5 2007 977 990
150. M. Large, S. Sharma, M.T. Compton, T. Slade, and O. Nielssen Cannabis use and earlier onset of psychosis: a systematic meta-analysis Arch Gen Psychiatry 68 6 2011 555 561
151. I. Lastres-Becker, F. Molina-Holgado, J.A. Ramos, R. Mechoulam, and J. Fernández-Ruiz Cannabinoids provide neuroprotection against 6-hydroxydopamine toxicity in vivo and in vitro: relevance to Parkinson's disease Neurobiol Dis 19 1 2005 96 107
152. J. Lawston, A. Borella, J.K. Robinson, and P.M. Whitaker-Azmitia Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2 Brain Res 877 2 2000 407 410
153. C. Lebel, F. Roussotte, and E.R. Sowell Imaging the impact of prenatal alcohol exposure on the structure of the developing human brain Neuropsychol Rev 21 2 2011 102 118
154. S. Leech, G.A. Richardson, L. Goldschmidt, and N. Day Prenatal substance exposure: effects on attention and impulsivity of 6-year-olds Neurotoxicol Teratol 21 2 1999 109 118
155. S. Lev-Ran, M. Roerecke, B. Le Foll, T.P. George, K. McKenzie, and J. Rehm The association between cannabis use and depression: a systematic review and meta-analysis of longitudinal studies Psychol Med 1-14 2013
156. A. Lichtman, K.R. Dimen, and B.R. Martin Systemic or intrahippocampal cannabinoid administration impairs spatial memory in rats Psychopharmacology (Berl) 119 3 1995 282 290
157. A. Lichtman, S. Varvel, and B. Martin Endocannabinoids in cognition and dependence Prostaglandins Leukot Essent Fatty Acids 66 2 2002 269 285
158. K.M. Lisdahl, E.R. Gilbart, N.E. Wright, and S. Shollenbarger Dare to delay? The impacts of adolescent alcohol and marijuana use onset on cognition, brain structure, and function Front Psychiatry 4 2013
159. A. LlorenteBerzal, S. Fuentes, H. Gagliano, M. LópezGallardo, A. Armario, and M.P. Viveros Sexdependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour Addict Biol 16 4 2011 624 637
160. M.P. Lopez-Larson, P. Bogorodzki, J. Rogowska, E. McGlade, J.B. King, and J. Terry Altered prefrontal and insular cortical thickness in adolescent marijuana users Behav Brain Res 220 1 2011 164 172
161. V. Lorenzetti, D. Lubman, A. Fornito, S. Whittle, M. Takagi, and N. Solowij The Impact of Regular Cannabis Use on the Human Brain: A Review of Structural Neuroimaging Studies Biological Research on Addiction: Comprehensive Addictive Behaviors and Disorders 2013 Academic Press San Diego 711 728
162. V. Lorenzetti, N. Solowij, A. Fornito, D. Lubman, and M. Yücel The association between regular cannabis exposure and alterations of human brain morphology: an updated review of the literature Curr Pharm Des 20 13 2014 2138 2167
163. R. Lujan, R. Shigemoto, and G. Lopez-Bendito Glutamate and GABA receptor signalling in the developing brain Neuroscience 130 3 2005 567 580
164. T. Lundqvist, S. Jönsson, and S. Warkentin Frontal lobe dysfunction in long-term cannabis users Neurotoxicol Teratol 23 5 2001 437 443
165. D.T. Malone, M.N. Hill, and T. Rubino Adolescent cannabis use and psychosis: epidemiology and neurodevelopmental models Br J Pharmacol 160 3 2010 511 522
166. D.T. Malone, D. Jongejan, and D.A. Taylor Cannabidiol reverses the reduction in social interaction produced by low dose Δ-9-tetrahydrocannabinol in rats Pharmacol Biochem Behav 93 2 2009 91 96
167. D.T. Malone, and D.A. Taylor The effect of Δ-9-tetrahydrocannabinol on sensorimotor gating in socially isolated rats Behav Brain Res 166 1 2006 101 109
168. Y. Marchalant, H.M. Brothers, and G.J. Norman Cannabinoids attenuate the effects of aging upon neuroinflammation and neurogenesis Neurobiol Dis 34 2 2009 300 307
169. Y. Marchalant, H.M. Brothers, and G.L. Wenk Cannabinoid agonist WIN-55,212-2 partially restores neurogenesis in the aged rat brain Mol Psychiatry 14 12 2009 1068
170. Y. Marchalant, F. Cerbai, and H.M. Brothers Cannabinoid receptor stimulation is anti-inflammatory and improves memory in old rats Neurobiol Aging 29 12 2008 1894 1901
171. G. Marsicano, S. Goodenough, K. Monory, H. Hermann, M. Eder, and A. Cannich CB1 cannabinoid receptors and on-demand defense against excitotoxicity Science 302 5642 2003 84 88
172. G. Marsicano, and P. Lafenêtre Roles of the endocannabinoid system in learning and memory Behavioral Neurobiology of the Endocannabinoid System 2009 201 230
173. R. Martin-Santos, A. Fagundo, J. Crippa, Z. Atakan, S. Bhattacharyya, and P. Allen Neuroimaging in cannabis use: a systematic review of the literature Psychol Med 40 3 2010 383 398
174. R.J. Mathew, S. Tant, and C. Burger Regional cerebral blood flow in marijuana smokers Br J Addict 81 4 1986 567 571
175. R.J. Mathew, W. Wilson, and S. Tant Acute changes in cerebral blood flow associated with marijuana smoking Acta Psychiatr Scand 79 2 1989 118 128
176. J.A. Matochik, D.A. Eldreth, J.-L. Cadet, and K.I. Bolla Altered brain tissue composition in heavy marijuana users Drug Alcohol Depend 77 1 2005 23 30
177. F. Mauler, V. Hinz, K.-H. Augstein, M. Faßbender, and E. Horváth Neuroprotective and brain edema-reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271 Brain Res 989 1 2003 99 111
178. J. McDonald, L. Schleifer, J.B. Richards, and H. de Wit Effects of THC on behavioral measures of impulsivity in humans Neuropsychopharmacology 28 7 2003 1356 1365
179. J.A. McLaren, E. Silins, D. Hutchinson, R.P. Mattick, and W. Hall Assessing evidence for a causal link between cannabis and psychosis: a review of cohort studies Int J Drug Policy 21 1 2010 10 19
180. T. McQueeny, C.B. Padula, J. Price, K.L. Medina, P. Logan, and S.F. Tapert Gender effects on amygdala morphometry in adolescent marijuana users Behav Brain Res 224 1 2011 128 134
181. K.L. Medina, K.L. Hanson, A.D. Schweinsburg, M. Cohen-Zion, B.J. Nagel, and S.F. Tapert Neuropsychological functioning in adolescent marijuana users: subtle deficits detectable after a month of abstinence J Int Neuropsychol Soc 13 05 2007 807 820
182. K.L. Medina, T. McQueeny, B.J. Nagel, K.L. Hanson, T.T. Yang, and S.F. Tapert Prefrontal cortex morphometry in abstinent adolescent marijuana users: subtle gender effects Addict Biol 14 4 2009 457 468
183. K.L. Medina, B.J. Nagel, A. Park, T. McQueeny, and S.F. Tapert Depressive symptoms in adolescents: associations with white matter volume and marijuana use J Child Psychol Psychiatry 48 6 2007 592 600
184. K.L. Medina, A.D. Schweinsburg, M. Cohen-Zion, B.J. Nagel, and S.F. Tapert Effects of alcohol and combined marijuana and alcohol use during adolescence on hippocampal volume and asymmetry Neurotoxicol Teratol 29 1 2007 141 152
185. M.H. Meier, A. Caspi, and A. Ambler Persistent cannabis users show neuropsychological decline from childhood to midlife Proc Natl Acad Sci 109 40 2012 E2657 E2664
186. G. Mereu, M. Fà, L. Ferraro, R. Cagiano, T. Antonelli, and M. Tattoli Prenatal exposure to a cannabinoid agonist produces memory deficits linked to dysfunction in hippocampal long-term potentiation and glutamate release Proc Natl Acad Sci 100 8 2003 4915 4920
187. C.L. Millsaps, R.L. Azrin, and W. Mittenberg Neuropsychological effects of chronic cannabis use on the memory and intelligence of adolescents J Child Adolesc Subst Abuse 3 1 1994 47 55
188. S.M. Minney, and H.H. López Adolescent cannabinoid treatment negatively affects reproductive behavior in female rats Pharmacol Biochem Behav 112 2013 82 88
189. A. Miyamoto, T. Yamamoto, and S. Watanabe Effect of repeated administration of Δ9-tetrahydrocannabinol on delayed matching-to-sample performance in rats Neurosci Lett 201 2 1995 139 142
190. F. Molina-Holgado, A. Amaro, M.I. González, F.J. Alvarez, and M.L. Leret Effect of maternal Δ9-tetrahydrocannabinol on developing serotonergic system Eur J Pharmacol 316 1 1996 39 42
191. E. Molina-Holgado, J.M. Vela, A. Arévalo-MartIÍn, G. Almazán, F. Molina-Holgado, and J. Borrell Cannabinoids promote oligodendrocyte progenitor survival: involvement of cannabinoid receptors and phosphatidylinositol-3 kinase/Akt signaling J Neurosci 22 22 2002 9742 9753
192. P. Monteleone, M. Bifulco, G. Maina, A. Tortorella, P. Gazzerro, and M.C. Proto Investigation of CNR1 and FAAH endocannabinoid gene polymorphisms in bipolar disorder and major depression Pharmacol Res 61 5 2010 400 404
193. T.H.M. Moore, S. Zammit, A. Lingford-Hughes, T.R.E. Barnes, P.B. Jones, and M. Burke Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review Lancet 370 9584 2007 319 328
194. F.A. Moreira, D.C. Aguiar, and F.S. Guimarães Anxiolytic-like effect of cannabidiol in the rat Vogel conflict test Prog Neuropsychopharmacol Biol Psychiatry 30 8 2006 1466 1471
195. F.A. Moreira, and F.S. Guimarães Cannabidiol inhibits the hyperlocomotion induced by psychotomimetic drugs in mice Eur J Pharmacol 512 2 2005 199 205
196. M. Morena, and P. Campolongo The endocannabinoid system: an emotional buffer in the modulation of memory function Neurobiol Learn Mem 112 2014 30 43
197. P. Morrison, V. Zois, D. McKeown, T. Lee, D. Holt, and J. Powell The acute effects of synthetic intravenous Δ9-tetrahydrocannabinol on psychosis, mood and cognitive functioning Psychol Med 39 10 2009 1607 1616
198. T. Nagayama, A.D. Sinor, R.P. Simon, J. Chen, S.H. Graham, and K. Jin Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures J Neurosci 19 8 1999 2987 2995
199. E.M. Nakamura, E.A. Da Silva, D. Adrian Wilkinson, and J. Masur Reversible effects of acute and long-term administration of Δ-9-tetrahydrocannabinol (THC) on memory in the rat Drug Alcohol Depend 28 2 1991 167 175
200. K.A. Newell, C. Deng, and X.-F. Huang Increased cannabinoid receptor density in the posterior cingulate cortex in schizophrenia Exp Brain Res 172 4 2006 556 560
201. R.J. Niesink, and M.W. van Laar Does cannabidiol protect against adverse psychological effects of THC? Front Psychiatry 4 2013
202. J.S. Noland, L.T. Singer, E.J. Short, S. Minnes, R.E. Arendt, and H. Lester Kirchner Prenatal drug exposure and selective attention in preschoolers Neurotoxicol Teratol 27 3 2005 429 438
203. M. O'Shea, M.E. Singh, I.S. McGregor, and P.E. Mallet Chronic cannabinoid exposure produces lasting memory impairment and increased anxiety in adolescent but not adult rats J Psychopharmacol 18 4 2004 502 508
204. D.S. O'Leary, R.I. Block, J.A. Koeppel, S.K. Schultz, V.A. Magnotta, and L.B. Ponto Effects of smoking marijuana on focal attention and brain blood flow Hum Psychopharmacol Clin Exp 22 3 2007 135 148
205. M. O'Shea, I.S. McGregor, and P.E. Mallet Repeated cannabinoid exposure during perinatal, adolescent or early adult ages produces similar longlasting deficits in object recognition and reduced social interaction in rats J Psychopharmacol 20 5 2006 611 621
206. D. Panikashvili, NaA Shein, R. Mechoulam, V. Trembovler, R. Kohen, and A. Alexandrovich The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines Neurobiol Dis 22 2 2006 257 264
207. D. Panikashvili, C. Simeonidou, S. Ben-Shabat, L. Hanuš, A. Breuer, and R. Mechoulam An endogenous cannabinoid (2-AG) is neuroprotective after brain injury Nature 413 6855 2001 527 531
208. D. Parolaro, N. Realini, D. Vigano, C. Guidali, and T. Rubino The endocannabinoid system and psychiatric disorders Exp Neurol 224 1 2010 3 14
209. T. Paus Mapping brain maturation and cognitive development during adolescence Trends Cogn Sci 9 2 2005 60 68
210. M. Perez, S.U. Benitez, L.P. Cartarozzi, E. del Bel, F.S. Guimaraes, and A.L. Oliveira Neuroprotection and reduction of glial reaction by cannabidiol treatment after sciatic nerve transection in neonatal rats Eur J Neurosci 38 10 2013 3424 3434
211. M. Pistis, S. Perra, G. Pillolla, M. Melis, A.L. Muntoni, and G.L. Gessa Adolescent exposure to cannabinoids induces long-lasting changes in the response to drugs of abuse of rat midbrain dopamine neurons Biol Psychiatry 56 2 2004 86 94
212. H.G. Pope, A.J. Gruber, J.I. Hudson, G. Cohane, M.A. Huestis, and D. Yurgelun-Todd Early-onset cannabis use and cognitive deficits: what is the nature of the association? Drug Alcohol Depend 69 3 2003 303 310
213. H.G. Pope, A.J. Gruber, J.I. Hudson, M.A. Huestis, and D. Yurgelun-Todd Neuropsychological performance in long-term cannabis users Arch Gen Psychiatry 58 10 2001 909
214. B.A. Primack, K.H. Kim, A. Shensa, J.E. Sidani, T.E. Barnett, and G.E. Switzer Tobacco, marijuana, and alcohol use in university students: a cluster analysis J Am Coll Health 60 5 2012 374 386
215. J. Quickfall, and D. Crockford Brain neuroimaging in cannabis use: a review J Neuropsychiatry Clin Neurosci 18 3 2006 318 332
216. H.R. Quinn, I. Matsumoto, P.D. Callaghan, L.E. Long, J.C. Arnold, and N. Gunasekaran Adolescent rats find repeated Δ9-THC less aversive than adult rats but display greater residual cognitive deficits and changes in hippocampal protein expression following exposure Neuropsychopharmacology 33 5 2008 1113 1126
217. J. Ramaekers, G. Kauert, E. Theunissen, S. Toennes, and M. Moeller Neurocognitive performance during acute THC intoxication in heavy and occasional cannabis users J Psychopharmacol 23 3 2009 266 277
218. J. Ramaekers, G. Kauert, P. van Ruitenbeek, E.L. Theunissen, E. Schneider, and M.R. Moeller High-potency marijuana impairs executive function and inhibitory motor control Neuropsychopharmacology 31 10 2006 2296 2303
219. M. Ranganathan, and D.C. D'souza The acute effects of cannabinoids on memory in humans: a review Psychopharmacology (Berl) 188 4 2006 425 444
220. N. Realini, D. Vigano, C. Guidali, E. Zamberletti, T. Rubino, and D. Parolaro Chronic URB597 treatment at adulthood reverted most depressive-like symptoms induced by adolescent exposure to THC in female rats Neuropharmacology 60 2 2011 235 243
221. J. Renard, M.-O. Krebs, T.M. Jay, and G. Le Pen Long-term cognitive impairments induced by chronic cannabinoid exposure during adolescence in rats: a strain comparison Psychopharmacology (Berl) 225 4 2013 781 790
222. L. Resstel, R.F. Tavares, S.F. Lisboa, S.R. Joca, F. Correa, and F.S. Guimaraes 5HT1A receptors are involved in the cannabidiolinduced attenuation of behavioural and cardiovascular responses to acute restraint stress in rats Br J Pharmacol 156 1 2009 181 188
223. G.Z. Reus, R.B. Stringari, K.F. Ribeiro, T. Luft, H.M. Abelaira, and G.R. Fries Administration of cannabidiol and imipramine induces antidepressantlike effects in the forced swimming test and increases brainderived neurotrophic factor levels in the rat amygdala Acta Neuropsychiatr 23 5 2011 241 248
224. T. Richardson Cannabis use and mental health: a review of recent epidemiological research Int J Pharmacol 6 6 2010 796 807
225. G.A. Richardson, C. Ryan, J. Willford, N.L. Day, and L. Goldschmidt Prenatal alcohol and marijuana exposure: effects on neuropsychological outcomes at 10 years Neurotoxicol Teratol 24 3 2002 309 320
226. M.J. Rivkin, P.E. Davis, J.L. Lemaster, H.J. Cabral, S.K. Warfield, and R.V. Mulkern Volumetric MRI study of brain in children with intrauterine exposure to cocaine, alcohol, tobacco, and marijuana Pediatrics 121 4 2008 741 750
227. O. Rogeberg Correlations between cannabis use and IQ change in the Dunedin cohort are consistent with confounding from socioeconomic status Proc Natl Acad Sci 110 11 2013 4251 4254
228. J. Romero, E. Garcia-Palomero, F. Berrendero, L. Garcia-Gil, M. Hernandez, and J. Ramos Atypical location of cannabinoid receptors in white matter areas during rat brain development Synapse 26 3 1997 317 323
229. T. Rubino, N.R. Daniela Vigano, C. Guidali, D. Braida, V. Capurro, and C. Castiglioni Chronic Δ9-tetrahydrocannabinol during adolescence provokes sex-dependent changes in the emotional profile in adult rats: behavioral and biochemical correlates Neuropsychopharmacology 33 11 2008 2760 2771
230. T. Rubino, and D. Parolaro Cannabis abuse in adolescence and the risk of psychosis: a brief review of the preclinical evidence Prog Neuropsychopharmacol Biol Psychiatry 52 2013 41 44
231. T. Rubino, E. Zamberletti, and D. Parolaro Adolescent exposure to cannabis as a risk factor for psychiatric disorders J Psychopharmacol 26 1 2012 177 188
232. Y. Sarne, F. Asaf, M. Fishbein, M. Gafni, and O. Keren The dual neuroprotective-neurotoxic profile of cannabinoid drugs Br J Pharmacol 163 7 2011 1391 1401
233. Y. Sarne, and R. Mechoulam Cannabinoids: between neuroprotection and neurotoxicity Curr Drug Targets CNS Neurol Disord 4 6 2005 677 684
234. A. Scallet Neurotoxicology of cannabis and THC: a review of chronic exposure studies in animals Pharmacol Biochem Behav 40 3 1991 671 676
235. A. Scallet, E. Uemura, A. Andrews, S. Ali, D. McMillan, and M. Paule Morphometric studies of the rat hippocampus following chronic delta-9-tetrahydrocannabinol (THC) Brain Res 436 1 1987 193 198
236. M. Schneider, and M. Koch The effect of chronic peripubertal cannabinoid treatment on deficient object recognition memory in rats after neonatal mPFC lesion Eur Neuropsychopharmacol 17 3 2007 180 186
237. M. Schneider, E. Schömig, and F.M. Leweke Preclinical study: acute and chronic cannabinoid treatment differentially affects recognition memory and social behavior in pubertal and adult rats Addict Biol 13 3-4 2008 345 357
238. N.L. Schramm-Sapyta, Y.M. Cha, S. Chaudhry, W.A. Wilson, H.S. Swartzwelder, and C.M. Kuhn Differential anxiogenic, aversive, and locomotor effects of THC in adolescent and adult rats Psychopharmacology (Berl) 191 4 2007 867 877
239. A.M. Schreiner, and M.E. Dunn Residual effects of cannabis use on neurocognitive performance after prolonged abstinence: a meta-analysis Exp Clin Psychopharmacol 20 5 2012 420
240. R.H. Schwartz, P.J. Gruenewald, M. Klitzner, and P. Fedio Short-term memory impairment in cannabis-dependent adolescents Am J Dis Child 143 10 1989 1214 1219
241. M. Segal, E. Korkotian, and D.D. Murphy Dendritic spine formation and pruning: common cellular mechanisms? Trends Neurosci 23 2 2000 53 57
242. S. Sevy, G.S. Smith, Y. Ma, V. Dhawan, T. Chaly, and P.B. Kingsley Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography Psychopharmacology (Berl) 197 4 2008 549 556
243. E.Y. Shen, S.F. Ali, and J.S. Meyer Chronic administration of THC prevents the behavioral effects of intermittent adolescent MDMA administration and attenuates MDMA-induced hyperthermia and neurotoxicity in rats Neuropharmacology 61 8 2011 1183 1192
244. W.S. Sheng, S. Hu, X. Min, G.A. Cabral, J.R. Lokensgard, and P.K. Peterson Synthetic cannabinoid WIN55, 212-2 inhibits generation of inflammatory mediators by IL1βstimulated human astrocytes Glia 49 2 2005 211 219
245. J.T. Sneider, H.G. Pope Jr., M.M. Silveri, N.S. Simpson, S.A. Gruber, and D.A. Yurgelun-Todd Differences in regional blood volume during a 28-day period of abstinence in chronic cannabis smokers Eur Neuropsychopharmacol 18 8 2008 612 619
246. N. Solowij, and R. Battisti The chronic effects of cannabis on memory in humans: a review Curr Drug Abuse Rev 1 1 2008 81 98
247. N. Solowij, K.A. Jones, M.E. Rozman, S.M. Davis, J. Ciarrochi, and P.C. Heaven Verbal learning and memory in adolescent cannabis users, alcohol users and non-users Psychopharmacology (Berl) 216 1 2011 131 144
248. N. Solowij, K.A. Jones, M.E. Rozman, S.M. Davis, J. Ciarrochi, and P.C. Heaven Reflection impulsivity in adolescent cannabis users: a comparison with alcohol-using and non-substance-using adolescents Psychopharmacology 219 2 2012 575 586
249. N. Solowij, and P.T. Michie Cannabis and cognitive dysfunction: parallels with endophenotypes of schizophrenia? J Psychiatry Neurosci 32 1 2007 30
250. N. Solowij, and N. Pesa Cannabis and cognition: short and long-term effects Marijuana and madness 2012 91 102
251. N. Solowij, R.S. Stephens, R.A. Roffman, T. Babor, R. Kadden, and M. Miller Cognitive functioning of long-term heavy cannabis users seeking treatment JAMA 287 9 2002 1123 1131
252. N. Solowij, M. Walterfang, D.I. Lubman, S. Whittle, V. Lorenzetti, and M. Styner Alteration to hippocampal shape in cannabis users with and without schizophrenia Schizophr Res 143 1 2013 179 184
253. N. Solowij, M. Yucel, V. Lorenzetti, and D. Lubman Does Cannabis Cause Lasting Brain Damage? 2012
254. N. Solowij, M. Yücel, C. Respondek, S. Whittle, E. Lindsay, and C. Pantelis Cerebellar white-matter changes in cannabis users with and without schizophrenia Psychol Med 41 11 2011 2349 2359
255. L.P. Spear The adolescent brain and age-related behavioral manifestations Neurosci Biobehav Rev 24 4 2000 417 463
256. N. Stefanis, P. Delespaul, C. Henquet, C. Bakoula, C. Stefanis, and J. Van Os Early adolescent cannabis exposure and positive and negative dimensions of psychosis Addiction 99 10 2004 1333 1341
257. L. Steinberg Cognitive and affective development in adolescence Trends Cogn Sci 9 2 2005 69 74
258. A. Stiglick, and H. Kalant Learning impairment in the radial-arm maze following prolonged cannabis treatment in rats Psychopharmacology (Berl) 77 2 1982 117 123
259. A. Stiglick, and H. Kalant Residual effects of prolonged cannabis administration on exploration and DRL performance in rats Psychopharmacology (Berl) 77 2 1982 124 128
260. A. Stiglick, and H. Kalant Residual effects of chronic cannabis treatment on behavior in mature rats Psychopharmacology (Berl) 85 4 1985 436 439
261. J. Suárez, R. Llorente, S.Y. RomeroZerbo, B. Mateos, F.J. BermúdezSilva, and F.R. de Fonseca Early maternal deprivation induces genderdependent changes on the expression of hippocampal CB1 and CB2 cannabinoid receptors of neonatal rats Hippocampus 19 7 2009 623 632
262. J. Suárez, P. Rivera, R. Llorente, S.Y. Romero-Zerbo, F.J. Bermúdez-Silva, and F.R. de Fonseca Early maternal deprivation induces changes on the expression of 2-AG biosynthesis and degradation enzymes in neonatal rat hippocampus Brain Res 1349 2010 162 173
263. J.M. Sullivan Cellular and molecular mechanisms underlying learning and memory impairments produced by cannabinoids Learn Mem 7 3 2000 132 139
264. I. Svíženská, P. Dubový, and A. Šulcová Cannabinoid receptors 1 and 2 (CB1 and CB2), their distribution, ligands and functional involvement in nervous system structures - a short review Pharmacol Biochem Behav 90 4 2008 501 511
265. B. Szabo, and E. Schlicker Effects of cannabinoids on neurotransmission Cannabinoids 2005 Springer 327 365
266. S.F. Tapert, E. Granholm, N.G. Leedy, and S.A. Brown Substance use and withdrawal: neuropsychological functioning over 8 years in youth J Int Neuropsychol Soc 8 7 2002 873 883
267. M.W. Tham, P.S. Woon, M.Y. Sum, T.-S. Lee, and K. Sim White matter abnormalities in major depression: evidence from post-mortem, neuroimaging and genetic studies J Affect Disord 132 1-2 2011 26
268. I. Tselnicker, O. Keren, A. Hefetz, C.G. Pick, and Y. Sarne A single low dose of tetrahydrocannabinol induces long-term cognitive deficits Neurosci Lett 411 2 2007 108 111
269. K. Tunving, S.O. Thulin, J. Risberg, and S. Warkentin Regional cerebral blood flow in long-term heavy cannabis use Psychiatry Res 17 1 1986 15 21
270. G.K. Tzilos, C.B. Cintron, J.B. Wood, N.S. Simpson, A.D. Young, and H.G. Pope Jr. Lack of hippocampal volume change in long-term heavy cannabis users Am J Addict 14 1 2005 64 72
271. M. Van der Stelt, W. Veldhuis, G. Van Haaften, F. Fezza, T. Bisogno, and P. Bär Exogenous anandamide protects rat brain against acute neuronal injury in vivo J Neurosci 21 22 2001 8765 8771
272. R. Van Winkel, and R. Kuepper Epidemiological, neurobiological, and genetic clues to the mechanisms linking cannabis use to risk for nonaffective psychosis Annu Rev Clin Psychol 10 2014 767 791
273. R.E. Vann, T.F. Gamage, J.A. Warner, E.M. Marshall, N.L. Taylor, and B.R. Martin Divergent effects of cannabidiol on the discriminative stimulus and place conditioning effects of Δ-9-tetrahydrocannabinol Drug Alcohol Depend 94 1 2008 191 198
274. C.D. Verrico, J.D. Jentsch, R.H. Roth, and J.R. Taylor Repeated, intermittent Δ9-tetrahydrocannabinol administration to rats impairs acquisition and performance of a test of visuospatial divided attention Neuropsychopharmacology 29 3 2004 522
275. K.Y. Vinod, V. Arango, S. Xie, S.A. Kassir, J.J. Mann, and T.B. Cooper Elevated levels of endocannabinoids and CB1 receptor-mediated G-protein signaling in the prefrontal cortex of alcoholic suicide victims Biol Psychiatry 57 5 2005 480 486
276. K.Y. Vinod, S.A. Kassir, B.L. Hungund, T.B. Cooper, J.J. Mann, and V. Arango Selective alterations of the CB1 receptors and the fatty acid amide hydrolase in the ventral striatum of alcoholics and suicides J Psychiatr Res 44 9 2010 591 597
277. M.P. Viveros, R. Llorente, J. Suarez, A. Llorente-Berzal, M. Lopez-Gallardo, and F. Rodriguez de Fonseca The endocannbinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications J Psychopharmacol 26 1 2012 164 176
278. N.D. Volkow, R.D. Baler, W.M. Compton, and S.R. Weiss Adverse health effects of marijuana use N Engl J Med 370 23 2014 2219 2227
279. N.D. Volkow, H. Gillespie, N. Mullani, L. Tancredi, C. Grant, and A. Valentine Brain glucose metabolism in chronic marijuana users at baseline and during marijuana intoxication Psychiatry Res Neuroimaging 67 1 1996 29 38
280. L. Walter, and N. Stella Cannabinoids and neuroinflammation Br J Pharmacol 141 5 2004 775 785
281. B. Wang, L. Deveaux, X. Li, S. Marshall, X. Chen, and B. Stanton The impact of youth, family, peer and neighborhood risk factors on developmental trajectories of risk involvement from early through middle adolescence Soc Sci Med 106 2014 43 52
282. T.D. Warner, M. Behnke, F.D. Eyler, K. Padgett, C. Leonard, and W. Hou Diffusion tensor imaging of frontal white matter and executive functioning in cocaine-exposed children Pediatrics 118 5 2006 2014 2024
283. N. Wegener, and M. Koch Behavioural disturbances and altered Fos protein expression in adult rats after chronic pubertal cannabinoid treatment Brain Res 1253 2009 81 91
284. C.T. Whitlow, C.S. Freedland, and L.J. Porrino Metabolic mapping of the time-dependent effects of Δ9-tetrahydrocannabinol administration in the rat Psychopharmacology (Berl) 161 2 2002 129 136
285. W.H. Wilson, E.H. Ellinwood, R.J. Mathew, and K. Johnson Effects of marijuana on performance of a computerized cognitive-neuromotor test battery Psychiatry Res 51 2 1994 115 125
286. W. Wilson, R. Mathew, T. Turkington, T. Hawk, R.E. Coleman, and J. Provenzale Brain morphological changes and early marijuana use: a magnetic resonance and positron emission tomography study J Addict Dis 19 1 2000 1 22
287. 11C] OMAR Neuroimage 52 4 2010 1505 1513
288. C.-S. Wu, C.P. Jew, and H.-C. Lu Lasting impacts of prenatal cannabis exposure and the role of endogenous cannabinoids in the developing brain Future Neurol 6 4 2011 459 480
289. T. Yim, N. Hong, M. Ejaredar, J. McKenna, and R. McDonald Post-training CB1 cannabinoid receptor agonist activation disrupts long-term consolidation of spatial memories in the hippocampus Neuroscience 151 4 2008 929 936
290. M. Yücel, E. Bora, D.I. Lubman, N. Solowij, W.J. Brewer, and S.M. Cotton The impact of cannabis use on cognitive functioning in patients with schizophrenia: a meta-analysis of existing findings and new data in a first-episode sample Schizophr Bull 38 2 2012 316 330
291. M. Yücel, D.I. Lubman, D. Velakoulis, M.T. Wong, S.J. Wood, and A. Condello Structural brain correlates of alcohol and cannabis use in recreational users Acta Neuropsychiatr 18 5 2006 226 229
292. M. Yücel, N. Solowij, C. Respondek, S. Whittle, A. Fornito, and C. Pantelis Regional brain abnormalities associated with long-term heavy cannabis use Arch Gen Psychiatry 65 6 2008 694
293. M. Yücel, A. Zalesky, M.J. Takagi, E. Bora, A. Fornito, and M. Ditchfield White-matter abnormalities in adolescents with long-term inhalant and cannabis use: a diffusion magnetic resonance imaging study J Psychiatry Neurosci 35 6 2010 409
294. A. Zalesky, N. Solowij, M. Yücel, D.I. Lubman, M. Takagi, and I.H. Harding Effect of long-term cannabis use on axonal fibre connectivity Brain 135 7 2012 2245 2255
295. T. Zanelati, C. Biojone, F. Moreira, F. Guimaraes, and S. Joca Antidepressantlike effects of cannabidiol in mice: possible involvement of 5HT1A receptors Br J Pharmacol 159 1 2010 122 128
296. 3H] SR141716A binding to cannabinoid CB1 receptors is increased in the anterior cingulate cortex in schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 28 2 2004 355 360
297. A. Zuardi, R. Cosme, F. Graeff, and F. Guimaraes Effects of ipsapirone and cannabidiol on human experimental anxiety J Psychopharmacol 7 1 Suppl. 1993 82 88
298. A. Zuardi, J. Crippa, J. Hallak, F. Moreira, and F. Guimaraes Cannabidiol, a Cannabis sativa constituent, as an antipsychotic drug Braz J Med Biol Res 39 4 2006 421 429
299. A. Zuardi, J.A. Rodrigues, and J. Cunha Effects of cannabidiol in animal models predictive of antipsychotic activity Psychopharmacology (Berl) 104 2 1991 260 264
300. A. Zuardi, I. Shirakawa, E. Finkelfarb, and I. Karniol Action of cannabidiol on the anxiety and other effects produced by Δ9-THC in normal subjects Psychopharmacology (Berl) 76 3 1982 245 250
301. L. Zuurman, A.E. Ippel, E. Moin, and J. Van Gerven Biomarkers for the effects of cannabis and THC in healthy volunteers Br J Clin Pharmacol 67 1 2009 5 21